Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07396701Phase 4Not yet recruiting
Phase 4, randomised, open-label trial in pneumonia and respiratory failure (3 arms), sponsored by Peking Union Medical College Hospital. Primary endpoint: 28-day mortality rate. Planned start Feb 2026; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07396701.